Q1 FY27 results dip YoY; dividend, director and auditor re-appointments approved
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.2 pts less than Nifty Smallcap 250 and 6.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Blue Jet Healthcare Q1 FY27 (June 2026) revenue from operations fell to Rs. 2,931.13 million from Rs. 3,547.58 million in Q1 FY26. PAT declined to Rs. 782.64 million from Rs. 911.70 million. EPS stood at Rs. 4.51 vs Rs. 5.26. Board set September 14, 2026 as record date for Rs. 1.2 per share (60%) dividend for FY26. Re-appointed Chairman Akshay Arora and MD Shiven Arora for 5 years each. KKC and Associates re-appointed as statutory auditors for a second term. 58th AGM scheduled for September 21, 2026.
Revenue and profit declined YoY but firm stays profitable; steady dividend signals management confidence in cash flows.